Inpharma Weekly

, Volume 1206, Issue 1, pp 11–12 | Cite as

Venlafaxine keeps the blues away

  • Carmen Innes
Newsletter Article


Wyeth-Ayerst’s venlafaxine [‘Effexor’] appears to provide better remission rates in patients with depression compared with selective serotonin reuptake inhibitors (SSRIs). These results, from a meta-analysis of 8 clinical studies, were presented at the 11th World Congress of Psychiatry [ Hamburg, Germany; August 1999 ]. Also presented were trials showing that venlafaxine improves cognition in elderly patients with depression compared with dothiepin, and that extended-release (XR) venlafaxine is effective in preventing relapse in patients with depression.


Venlafaxine Major Depressive Disorder 11th World Relapse Prevention Dothiepin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Carmen Innes

There are no affiliations available

Personalised recommendations